These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28398481)

  • 1. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
    Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R
    Hum Mol Genet; 2017 May; 26(9):1785. PubMed ID: 28398481
    [No Abstract]   [Full Text] [Related]  

  • 2. MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
    Musso G; Cassader M; De Michieli F; Paschetta E; Pinach S; Saba F; Bongiovanni D; Framarin L; Berrutti M; Leone N; Corvisieri S; Parente R; Molinaro F; Sircana A; Bo S; Gambino R
    Hum Mol Genet; 2017 May; 26(9):1747-1758. PubMed ID: 28334911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease.
    Petta S; Valenti L; Marra F; Grimaudo S; Tripodo C; Bugianesi E; Cammà C; Cappon A; Di Marco V; Di Maira G; Dongiovanni P; Rametta R; Gulino A; Mozzi E; Orlando E; Maggioni M; Pipitone RM; Fargion S; Craxì A
    J Hepatol; 2016 Mar; 64(3):682-90. PubMed ID: 26596542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
    Lê KA; Bortolotti M
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
    Yki-Järvinen H
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
    Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
    Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.
    Musso G; Gambino R; Pacini G; Pagano G; Durazzo M; Cassader M
    Hepatology; 2009 Feb; 49(2):426-35. PubMed ID: 19105201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.
    Musso G; Gambino R; De Michieli F; Durazzo M; Pagano G; Cassader M
    Hepatology; 2008 Apr; 47(4):1167-77. PubMed ID: 18311774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.
    Dâmaso AR; do Prado WL; de Piano A; Tock L; Caranti DA; Lofrano MC; Carnier J; Cristofalo DJ; Lederman H; Tufik S; de Mello MT
    Dig Liver Dis; 2008 Feb; 40(2):132-9. PubMed ID: 18082476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
    Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.
    Sozio MS; Liangpunsakul S; Crabb D
    Semin Liver Dis; 2010 Nov; 30(4):378-90. PubMed ID: 20960377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein metabolism mediates the association of MTP polymorphism with beta-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis.
    Musso G; Gambino R; Cassader M
    J Nutr Biochem; 2010 Sep; 21(9):834-40. PubMed ID: 19733470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Mellitus: Management of Gastrointestinal Complications.
    Careyva B; Stello B
    Am Fam Physician; 2016 Dec; 94(12):980-986. PubMed ID: 28075092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity.
    Georgoulis M; Fragopoulou E; Kontogianni MD; Margariti A; Boulamatsi O; Detopoulou P; Tiniakos D; Zafiropoulou R; Papatheodoridis G
    Nutr Res; 2015 Jan; 35(1):41-8. PubMed ID: 25530013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.